Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (KQ:307750) — Market Cap & Net Worth
Market Cap & Net Worth: Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750)
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (KQ:307750) has a market capitalization of $132.95 Million (₩196.19 Billion) as of May 3, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #18096 globally and #891 in its home market, demonstrating a 0.77% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Daishin Balance No.6 Special Purpose Acquisition Co. Ltd's stock price ₩3910.00 by its total outstanding shares 50176263 (50.18 Million). Analyse 307750 cash flow metrics to see how efficiently the company converts income to cash.
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd Market Cap History: 2018 to 2026
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd's market capitalization history from 2018 to 2026. Data shows growth from $63.31 Million to $132.95 Million (10.67% CAGR).
Index Memberships
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$299.07 Billion | 0.04% | #363 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$299.07 Billion | 0.04% | #363 of 1384 |
Weight: Daishin Balance No.6 Special Purpose Acquisition Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Daishin Balance No.6 Special Purpose Acquisition Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.07x
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd's market cap is 0.07 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $313.40 Million | $80.62 Billion | -$3.32 Billion | 0.00x | N/A |
| 2021 | $371.77 Million | $85.35 Billion | $4.04 Billion | 0.00x | 0.09x |
| 2022 | $225.10 Million | $103.71 Billion | $8.95 Billion | 0.00x | 0.03x |
| 2023 | $212.18 Million | $122.00 Billion | $4.82 Billion | 0.00x | 0.04x |
| 2024 | $119.52 Million | $136.47 Billion | $1.74 Billion | 0.00x | 0.07x |
Competitor Companies of 307750 by Market Capitalization
Companies near Daishin Balance No.6 Special Purpose Acquisition Co. Ltd in the global market cap rankings as of May 3, 2026.
Key companies related to Daishin Balance No.6 Special Purpose Acquisition Co. Ltd by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #16 globally with a market cap of $862.20 Billion USD.
- Eli Lilly and Company (SA:LILY34): Ranked #17 globally with a market cap of $853.51 Billion USD ( R$4.35 Trillion BRL).
- Johnson & Johnson (NYSE:JNJ): Ranked #23 globally with a market cap of $547.37 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #37 globally with a market cap of $365.30 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #16 | Eli Lilly and Company | NYSE:LLY | $862.20 Billion | $963.33 |
| #17 | Eli Lilly and Company | SA:LILY34 | $853.51 Billion | R$153.70 |
| #23 | Johnson & Johnson | NYSE:JNJ | $547.37 Billion | $227.19 |
| #37 | AbbVie Inc | NYSE:ABBV | $365.30 Billion | $206.60 |
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd Historical Marketcap From 2018 to 2026
Between 2018 and today, Daishin Balance No.6 Special Purpose Acquisition Co. Ltd's market cap moved from $63.31 Million to $ 132.95 Million, with a yearly change of 10.67%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩132.95 Million | +16.20% |
| 2025 | ₩114.42 Million | -4.27% |
| 2024 | ₩119.52 Million | -43.67% |
| 2023 | ₩212.18 Million | -5.74% |
| 2022 | ₩225.10 Million | -39.45% |
| 2021 | ₩371.77 Million | +18.62% |
| 2020 | ₩313.40 Million | +392.57% |
| 2019 | ₩63.63 Million | +0.50% |
| 2018 | ₩63.31 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $132.95 Million USD |
| MoneyControl | $132.95 Million USD |
| MarketWatch | $132.95 Million USD |
| marketcap.company | $132.95 Million USD |
| Reuters | $132.95 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Daishin Balance No.6 Special Purpose Acquisition Co. Ltd
KUKJEON PHARMACEUTICAL Co., Ltd operates as a chemical total solutions provider in South Korea. It provides various chemical-based products and services; and after-sales services, such as research and development, production, quality control, and DMF services. The company manufactures active pharmaceutical ingredients; and offers molecular design and technical support. It develops electronic mate… Read more